Cyclacel Pharmaceuticals Inc (CYCC)
0.40
-0.06
(-12.09%)
USD |
NASDAQ |
Nov 14, 10:26
Cyclacel Pharmaceuticals Price to Book Value: 0.7905 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.8992 |
| November 12, 2024 | 0.8102 |
| November 11, 2024 | 0.8873 |
| November 08, 2024 | 0.9505 |
| November 07, 2024 | 0.8413 |
| November 06, 2024 | 0.8203 |
| November 05, 2024 | 0.8737 |
| November 04, 2024 | 0.998 |
| November 01, 2024 | 1.239 |
| October 31, 2024 | 1.282 |
| October 30, 2024 | 1.298 |
| October 29, 2024 | 1.344 |
| October 28, 2024 | 1.383 |
| October 25, 2024 | 1.644 |
| October 24, 2024 | 1.721 |
| October 23, 2024 | 2.095 |
| October 22, 2024 | 2.826 |
| October 21, 2024 | 2.609 |
| October 18, 2024 | 2.253 |
| October 17, 2024 | 1.996 |
| October 16, 2024 | 1.956 |
| October 15, 2024 | 1.607 |
| October 14, 2024 | 1.581 |
| October 11, 2024 | 1.581 |
| October 10, 2024 | 1.572 |
| Date | Value |
|---|---|
| October 09, 2024 | 1.587 |
| October 08, 2024 | 1.759 |
| October 07, 2024 | 1.858 |
| October 04, 2024 | 1.805 |
| October 03, 2024 | 1.818 |
| October 02, 2024 | 1.838 |
| October 01, 2024 | 1.878 |
| September 30, 2024 | 1.956 |
| September 27, 2024 | 2.036 |
| September 26, 2024 | 1.976 |
| September 25, 2024 | 2.016 |
| September 24, 2024 | 2.036 |
| September 23, 2024 | 1.956 |
| September 20, 2024 | 1.937 |
| September 19, 2024 | 2.016 |
| September 18, 2024 | 2.065 |
| September 17, 2024 | 2.016 |
| September 16, 2024 | 2.036 |
| September 13, 2024 | 1.996 |
| September 12, 2024 | 2.095 |
| September 11, 2024 | 2.154 |
| September 10, 2024 | 2.095 |
| September 09, 2024 | 2.174 |
| September 06, 2024 | 2.095 |
| September 05, 2024 | 2.075 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2551
Minimum
Dec 28 2022
6.448
Maximum
Feb 16 2024
1.218
Average
0.8563
Median
Jan 20 2022
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.9074 |
| Theriva Biologics Inc | 0.0516 |
| Oragenics Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 6.042 |
| Price | 0.40 |
| Earnings Yield | -4.10K% |
| Market Cap | 0.7897M |